Ainex successfully showcased ENAD, our AI-powered real-time diagnostic assistance software for upper and lower GI endoscopy, at the 16th Singapore Gastric Cancer Consortium Annual Scientific Meeting (SGCC ASM 2026), held in Singapore on July 15–16.

As one of the Asia-Pacific region's most influential gastric cancer platforms, SGCC ASM drew keen interest to ENAD CAD-Gx — our AI solution for identifying early gastric cancer and precancerous lesions. Its ability to detect and characterize a wide range of gastric lesions in real time — including Advanced Gastric Cancer (AGC), Early Gastric Cancer (EGC), Adenoma, and Intestinal Metaplasia — resonated strongly with leading gastric cancer specialists.

What made this year especially meaningful was that researchers from both Korea and Singapore presented directly on ENAD's clinical applications. Professor Cheol Min Shin of Seoul National University Bundang Hospital delivered "Applications of AI in Gastric Cancer," illustrating AI's clinical utility in early gastric cancer detection through real cases, while Professor Jonathan W. J. Lee of National University Hospital (NUH), Singapore, presented "Optimizing AI-assisted Upper Gastrointestinal Endoscopy," drawing on real-world experience accumulated through joint studies conducted since NUH signed an MOU with Ainex in 2024.

"It was a particularly meaningful gathering — one where ENAD's academic evidence and real-world clinical experience were shared widely." Ainex will continue to expand clinical collaborations with leading medical institutions at home and abroad, strengthening our global position as an AI solution that delivers meaningful support to clinicians.

#SGCCASM2026 #SGCC #ENAD #Ainex #NUH #Singapore #GastricCancer #EarlyDetection #AinexCorporation #EndoscopyAI #ainexcorp